Getting Takhzyro (Lanadelumab) Covered by Humana in Illinois: Complete Coverage Guide with Forms and Appeal Process
Answer Box: Your Fastest Path to Takhzyro Coverage
Takhzyro (lanadelumab-flyo) requires prior authorization from Humana in Illinois. You'll need confirmed HAE Type I/II diagnosis (low C4 and C1-INH levels), documented attack frequency, and proof of failure/contraindication to Haegarda or similar prophylaxis. Start today by: (1) gathering